DOTAREM SOLUTION Canada - English - Health Canada

dotarem solution

guerbet - gadoterate meglumine - solution - 376.9mg - gadoterate meglumine 376.9mg - other diagnostic agents

VASOVIST- gadofosveset trisodium injection United States - English - NLM (National Library of Medicine)

vasovist- gadofosveset trisodium injection

bayer healthcare, inc. - gadofosveset trisodium (unii: xm33q67uvh) (gadofosveset - unii:e65rw73phs) - injection - 244 mg in 1 ml - vasovist is indicated for use as a contrast agent in magnetic resonance angiography (mra) to evaluate aortoiliac occlusive disease (aiod) in adults with known or suspected peripheral vascular disease [see clinical studies (14) ]. history of a prior allergic reaction to a gadolinium-based contrast agent. pregnancy category c there are no adequate and well-controlled studies of vasovist in pregnant women. in animal studies, pregnant rabbits treated with gadofosveset trisodium at doses 3 times the human dose (based on body surface area) experienced higher rates of fetal loss and resorptions. because animal reproduction studies are not always predictive of human response, only use vasovist during pregnancy if the diagnostic benefit justifies the potential risks to the fetus. in reproductive studies, pregnant rats and rabbits received gadofosveset trisodium at various doses up to approximately 11 (rats) and 21.5 (rabbits) times the human dose (based on body surface area). the highest dose resulted in maternal t

OPTIMARK SOLUTION Canada - English - Health Canada

optimark solution

liebel-flarsheim canada inc - gadoversetamide - solution - 330.9mg - gadoversetamide 330.9mg - other diagnostic agents

MAGNEVIST- gadopentetate dimeglumine injection United States - English - NLM (National Library of Medicine)

magnevist- gadopentetate dimeglumine injection

bayer healthcare pharmaceuticals inc. - gadopentetate dimeglumine (unii: rh248g8v27) (gadopentetate - unii:v7ok6j19hq) - magnevist injection is indicated for use with magnetic resonance imaging (mri) in adults, and pediatric patients (2 years of age and older) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. magnevist injection has been shown to facilitate visualization of intracranial lesions including but not limited to tumors. magnevist injection is indicated for use with mri in adults and pediatric patients (2 years of age and older) to facilitate the visualization of lesions with abnormal vascularity in the head and neck. magnevist injection is indicated for use in mri in adults and pediatric patients (2 years of age and older) to facilitate the visualization of lesions with abnormal vascularity in the body. magnevist is contraindicated in patients with: gbcas cross the placenta and result in fetal exposure and gadolinium retention. the human data on the association between gbcas and adverse fetal outcomes are limited and inconclusive (see data). in animal

Ulrich CT Injector missouri™ (XD 2001) Singapore - English - HSA (Health Sciences Authority)

ulrich ct injector missouri™ (xd 2001)

qt instruments (s) pte ltd - radiology / imaging - the injector missouri™ xd 2001 is designed for the intravenous, application of non-radioactive contrast agent to improve image quality for computer tomography imaging with ct- and pet-ct scanners – except high pressure angiographic examinations

Ulrich CT Injector ohio tandem™ with tandem function (XD 2002) Singapore - English - HSA (Health Sciences Authority)

ulrich ct injector ohio tandem™ with tandem function (xd 2002)

qt instruments (s) pte ltd - radiology / imaging - the injector ohio tandem™ xd 2002 is designed for the intravenous, application of non-radioactive contrast agent to improve image quality for computer tomography imaging with ct- and pet-ct scanners – except high pressure angiographic examinations

Ulrich CTMRI Contrast Agent Injector Tennessee (XD 2003) Singapore - English - HSA (Health Sciences Authority)

ulrich ctmri contrast agent injector tennessee (xd 2003)

qt instruments (s) pte ltd - radiology / imaging - the injector xd 2003 tennessee™ is designed for the intravenous, application of non-radioactive contrast agent to improve image quality for nuclear magnetic resonance imaging respectively computer tomography imaging with mri, ct- and pet-ct scanners – except high pressure angiographic examinations

Ulrich CTMRI Injector mississippi™ (XD 2000) Singapore - English - HSA (Health Sciences Authority)

ulrich ctmri injector mississippi™ (xd 2000)

qt instruments (s) pte ltd - radiology / imaging - the injector mississippi™ xd 2000 is designed for the intravenous, application of non-radioactive contrast agent to improve image quality for nuclear magnetic resonance imaging respectively computer tomography imaging with mri, ct- and pet-ct scanners – except high pressure angiographic examinations

Ulrich CTMRI Injector ohio M™ (XD 2004) Singapore - English - HSA (Health Sciences Authority)

ulrich ctmri injector ohio m™ (xd 2004)

qt instruments (s) pte ltd - radiology / imaging - the injector ohio m™ xd 2004 is designed for the intravenous, application of non-radioactive contrast agent to improve image quality for nuclear magnetic resonance imaging respectively computer tomography imaging with mri, ct- and pet-ct scanners – except high pressure angiographic examinations

GADOPENTETATE DIMEGLUMINE INJECTION SOLUTION Canada - English - Health Canada

gadopentetate dimeglumine injection solution

avir pharma inc. - gadopentetate dimeglumine - solution - 469mg - gadopentetate dimeglumine 469mg - miscellaneous therapeutic agents